BBHC
LGND icon

Brown Brothers Harriman & Co’s Ligand Pharmaceuticals LGND Stock Holding History

Brown Brothers Harriman & Co’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.2K Buy
56
+10
+22% +$1.98K ﹤0.01% 1336
2025
Q4 		$8.7K Buy
+46
New +$8.84K ﹤0.01% 1371
2025
Q1 		– Sell
-48
Closed -$5.14K – 1398
2024
Q4 		$5.14K Hold
48
– – ﹤0.01% 1227
2024
Q3 		$4.8K Buy
+48
New +$4.83K ﹤0.01% 1159
2020
Q1 		– Sell
-462
Closed -$30K – 1211
2019
Q4 		$30K Buy
+462
New +$30.9K ﹤0.01% 742
2018
Q1 		– Sell
-236
Closed -$20K – 984
2017
Q4 		$20K Buy
+236
New +$20.5K ﹤0.01% 648

Other funds holding LGND

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return